123018-27-9

Basic information

• Product Name: 2-(3-bromo-5-methoxyphenyl)acetonitrile
• Synonyms: 2-(3-bromo-5-methoxyphenyl)acetonitrile;(3-Bromo-5-methoxy-phenyl)-acetonitrile
• CAS NO: 123018-27-9
• Molecular Formula: C₉H₈BrNO
• Molecular Weight: 226.06992
• Mol File: 123018-27-9.mol

Chemical Properties

• Boiling Point: 321.8±27.0 °C(Predicted)
• Appearance: /
• Density: 1.450±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-(3-bromo-5-methoxyphenyl)acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-bromo-5-methoxyphenyl)acetonitrile(123018-27-9)
• EPA Substance Registry System: 2-(3-bromo-5-methoxyphenyl)acetonitrile(123018-27-9)

Safety Data

• Hazardous Substances Data: 123018-27-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
2-(3-bromo-5-methoxyphenyl)acetonitrile is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique structure allows for the creation of a wide range of medicinal compounds, contributing to the development of new treatments and therapies.
Used in Agrochemical Production:
In the agrochemical industry, 2-(3-bromo-5-methoxyphenyl)acetonitrile serves as a key intermediate in the production of pesticides and other crop protection agents. Its incorporation into these products helps to enhance their effectiveness in protecting crops from pests and diseases, thereby supporting agricultural productivity.
Used in Organic Synthesis:
2-(3-bromo-5-methoxyphenyl)acetonitrile is utilized as a versatile building block in organic synthesis across various chemical industries. Its unique functional groups and structural features make it suitable for the creation of a diverse array of organic compounds, including specialty chemicals, dyes, and other materials with specific applications.

Upstream product

• 262450-64-6 (3-bromo-5-methoxyphenyl)methanol 
• 157893-14-6 3-bromo-5-methoxybenzoic acid 
• 7677-24-9 trimethylsilyl cyanide 
• 59297-29-9 1-bromo-3-(bromomethyl)-5-methoxybenzene 
• 29578-83-4 3-bromo-5-methoxytoluene 
• 74204-00-5 3-bromo-5-methylphenol 
• 773837-37-9 sodium cyanide 
• 1260742-30-0 C₈H₈BrClO 
• 143-33-9 sodium cyanide 

Downstream Products

• 262450-67-9 2-(3-bromo-5-methoxyphenyl)ethylamine 
• 1220694-87-0 8-bromo-6-methoxy-1,2,3,4-tetrahydroisoquinoline 
• 1261476-25-8 methyl 2-(3-bromo-5-methoxyphenyl)acetate 
• 934241-94-8 (3-bromo-5-hydroxyphenyl)acetic acid 

Relevant articles and documents

SMALL MOLECULE AUTOPHAGY INDUCERS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES

Disclosed herein are compounds and methods for treating cancer and neurodegenerative diseases. In some examples, the compounds increase autophagy.

HETEROCYCLIC CARBOXYLIC ACIDS AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R5, R6, R7, R8, R9, B, V, W, X, Y, Z and m are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

ALKOXY PYRAZOLES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The inventi

8-Substituted isoquinoline derivative and the use thereof

The present invention relates to a compound represented by the following formula (1): wherein D1, A1, D2, R1, D3, and R2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.

Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease

The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory-disorders, pharmaceutical compositions containing them, and processes for their preparation.

NOVEL COMPOUNDS

The invention relates to substituted phenylacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzazepines and their use in treating gastrointestinal motility disorders

Sulfinyl and sulfonyl substituted 3-benzazepine compounds are useful in treating gastrointestinal motility disorders and emesis. A particular compound of this invention is 7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine.

Sulfinyl and sulfonyl substituted 3-benzazepines

Sulfinyl and sulfonyl substituted 3-benzazepine compounds are useful in treating gastrointestinal motility disorders. A particular compound of this invention is 8-hydroxy-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine.